LYSDY vs. AYTU

Last updated Apr 2, 2026

Compare and contrast key facts about Lynas Rare Earths Ltd ADR (LYSDY) and Aytu BioPharma, Inc. (AYTU).

Performance

LYSDY vs. AYTU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lynas Rare Earths Ltd ADR (LYSDY) and Aytu BioPharma, Inc. (AYTU). The values are adjusted to include any dividend payments, if applicable.

LYSDY vs. AYTU - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
LYSDY Lynas Rare Earths Ltd ADR	64.93%	109.37%	-18.22%	-8.17%	-29.21%	144.41%	79.88%	50.87%	489.58%	171.43%
AYTU Aytu BioPharma, Inc.	1.54%	52.94%	-40.14%	-24.87%	-86.00%	-77.42%	-38.35%	22.41%	-98.22%	-88.85%

Fundamentals

Market Cap LYSDY : $13.41B AYTU : $26.50M
EPS LYSDY : $0.14 AYTU : -$2.02
PS Ratio LYSDY : 11.01 AYTU : 0.51
PB Ratio LYSDY : 3.99 AYTU : 1.87
Total Revenue (TTM) LYSDY : $1.19B AYTU : $62.64M
Gross Profit (TTM) LYSDY : $301.27M AYTU : $41.34M
EBITDA (TTM) LYSDY : $236.57M AYTU : -$17.24M

Returns By Period

In the year-to-date period, LYSDY achieves a 64.93% return, which is significantly higher than AYTU's 1.54% return.

LYSDY

• 1D: 1.19%
• 1M: -4.28%
• YTD: 64.93%
• 6M: 20.39%
• 1Y: 204.46%
• 3Y*: 47.62%
• 5Y*: 23.78%
• 10Y*: 74.87%

AYTU

• 1D: -3.30%
• 1M: -0.00%
• YTD: 1.54%
• 6M: 41.18%
• 1Y: 127.59%
• 3Y*: 5.63%
• 5Y*: -55.49%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

LYSDY vs. AYTU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LYSDY

LYSDY Risk / Return Rank: 92
LYSDY Sharpe Ratio Rank: 96
LYSDY Sortino Ratio Rank: 92
LYSDY Omega Ratio Rank: 90
LYSDY Calmar Ratio Rank: 92
LYSDY Martin Ratio Rank: 88

AYTU

AYTU Risk / Return Rank: 85
AYTU Sharpe Ratio Rank: 75
AYTU Sortino Ratio Rank: 91
AYTU Omega Ratio Rank: 89
AYTU Calmar Ratio Rank: 84
AYTU Martin Ratio Rank: 84

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LYSDY vs. AYTU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lynas Rare Earths Ltd ADR (LYSDY) and Aytu BioPharma, Inc. (AYTU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LYSDY	AYTU	Difference
Sharpe ratio Return per unit of total volatility	3.09	1.09	+2.00
Sortino ratio Return per unit of downside risk	3.13	3.01	+0.12
Omega ratio Gain probability vs. loss probability	1.39	1.39	0.00
Calmar ratio Return relative to maximum drawdown	4.53	2.83	+1.70
Martin ratio Return relative to average drawdown	9.61	7.53	+2.07
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LYSDY vs. AYTU - Sharpe Ratio Comparison

The current LYSDY Sharpe Ratio is 3.09, which is higher than the AYTU Sharpe Ratio of 1.09. The chart below compares the historical Sharpe Ratios of LYSDY and AYTU, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	LYSDY	AYTU	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	3.09	1.09	+2.00
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.47	-0.65	+1.12
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.27	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.03	-0.36	+0.39

Correlation

The correlation between LYSDY and AYTU is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

LYSDY vs. AYTU - Dividend Comparison

Neither LYSDY nor AYTU has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

LYSDY vs. AYTU - Drawdown Comparison

The maximum LYSDY drawdown since its inception was -99.93%, roughly equal to the maximum AYTU drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for LYSDY and AYTU.

Drawdown Indicators

	LYSDY	AYTU	Difference
Max Drawdown Largest peak-to-trough decline	-99.93%	-100.00%	+0.07%
Max Drawdown (1Y) Largest decline over 1 year	-46.39%	-42.47%	-3.92%
Max Drawdown (5Y) Largest decline over 5 years	-58.25%	-99.34%	+41.09%
Max Drawdown (10Y) Largest decline over 10 years	-72.35%	—	—
Current Drawdown Current decline from peak	-50.67%	-100.00%	+49.33%
Average Drawdown Average peak-to-trough decline	-84.92%	-95.05%	+10.13%
Ulcer Index Depth and duration of drawdowns from previous peaks	21.86%	15.93%	+5.93%

Volatility

LYSDY vs. AYTU - Volatility Comparison

Lynas Rare Earths Ltd ADR (LYSDY) has a higher volatility of 18.70% compared to Aytu BioPharma, Inc. (AYTU) at 10.33%. This indicates that LYSDY's price experiences larger fluctuations and is considered to be riskier than AYTU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LYSDY	AYTU	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.70%	10.33%	+8.37%
Volatility (6M) Calculated over the trailing 6-month period	53.18%	38.47%	+14.71%
Volatility (1Y) Calculated over the trailing 1-year period	66.71%	117.92%	-51.21%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	50.34%	85.84%	-35.50%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	279.44%	190.00%	+89.44%

Financials

LYSDY vs. AYTU - Profitability Comparison

The chart below illustrates the profitability comparison between Lynas Rare Earths Ltd ADR and Aytu BioPharma, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

LYSDY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Lynas Rare Earths Ltd ADR reported a gross profit of 114.53M and revenue of 406.10M. Therefore, the gross margin over that period was 28.2%.

AYTU - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Aytu BioPharma, Inc. reported a gross profit of 9.10M and revenue of 15.17M. Therefore, the gross margin over that period was 60.0%.

LYSDY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Lynas Rare Earths Ltd ADR reported an operating income of 79.26M and revenue of 406.10M, resulting in an operating margin of 19.5%.

AYTU - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Aytu BioPharma, Inc. reported an operating income of -1.97M and revenue of 15.17M, resulting in an operating margin of -13.0%.

LYSDY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Lynas Rare Earths Ltd ADR reported a net income of 78.74M and revenue of 406.10M, resulting in a net margin of 19.4%.

AYTU - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Aytu BioPharma, Inc. reported a net income of -10.58M and revenue of 15.17M, resulting in a net margin of -69.8%.